← SynDRA
ESTRAMUSTINE PHOSPHATE
SynDRA canonical compound SYN0020302 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | MAP2 |
|---|
| Mechanism of action | Estrogen receptor agonist |
|---|
| Indication | prostate cancer |
|---|
| Disease area | oncology |
|---|
All known targets
- ESR2
- ESR1
- MAP1A
- MAP2
- INPPL1
- PTPN1
- PTPN11
- PTPN6
Mechanisms of action (all sources)
- DNA inhibitor
- DNA alkylating agent
- microtubule inhibitor
- DNA synthesis inhibitor
- ESR1 AGONIST
- ESR2 MODULATOR
Drug classes
- Alkylating Agents
- Antineoplastic Agents
- Antineoplastic Agents, Alkylating
- Antineoplastic Agents, Hormonal
- Noxae
Cross-references
Synonyms
- emcyt
- estramustine phosphate sodium
- Estramustine 17-(dihydrogen phosphate)
- Ls-299
- NSC-89199
- Estracyt
- estramustine-phosphate
- estramustine.phosphate
- Emcyt (free acid)
- Leo 299
- LS-299
- NSC 89199
- CHEMBL1756
- MUZ9585Y7B
- CHEBI:68643
- (8R,9S,13S,14S,17S)-13-Methyl-17-(phosphonooxy)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl bis(2-chloroethyl)carbamate
- Estradiol, 3-(bis(2-chloroethyl)carbamate) dihydrogen phosphate
- Estra-1,3,5(10)-triene-3,17beta-diol 3-[bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate)
- Estradiol, 3-[bis(2-chloroethyl)carbamate] dihydrogen phosphate
- (17beta)-17-(phosphonooxy)estra-1(10),2,4-trien-3-yl bis(2-chloroethyl)carbamate
- UNII-MUZ9585Y7B
- NCGC00184995-01
- Estra-1,3,5(10)-triene-3,17beta-diol 3-(bis(2-chloroethyl)carbamate) 17-(dihydrogen phosphate)
- NSC89199
- EINECS 225-512-3
- BRN 1898199
- SCHEMBL234749
- DTXSID7048667
- ZINC3938713
- Tox21_113033
- BDBM50333645
- HY-13627A
- AKOS025401368
- AC-1305
- DB14674
- ESTRAMUSTINE PHOSPHATE [WHO-DD]
- NCGC00484900-01
- [(8R,9S,13S,14S,17S)-13-methyl-17-phosphonooxy-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] N,N-bis(2-chloroethyl)carbamate
Look up ESTRAMUSTINE PHOSPHATE in the interactive SynDRA portal →